REGISTRATION OF THE PRODUCTS Sample Clauses

REGISTRATION OF THE PRODUCTS. 1. During the TERM and the ADDITIONAL TERM, IOMED shall be responsible for filing and prosecuting all NDAs and other applications for regulatory approvals. ELAN shall transfer the INDs held by it in relation to the PRODUCTS. IOMED or its sublicensees shall file the NDAs with the FDA and will use its reasonable efforts in prosecuting said NDA to approval. IOMED shall thereafter maintain at its own cost the NDAs with the FDA for the term of this Agreement. Subject to IOMED's reasonable discretion IOMED hereby agrees to provide to ELAN at ELAN's own cost access to such NDAs as ELAN reasonably requests. ****. For the avoidance of doubt, the parties agree that all information furnished to ELAN pursuant to this Paragraph shall Institute CONFIDENTIAL INFORMATION for the purposes of this Agreement. 17
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
REGISTRATION OF THE PRODUCTS. 1. During the TERM and the ADDITIONAL TERM, IOMED shall be responsible for filing and prosecuting all NDAs and other applications for regulatory approvals. IOMED or its sublicensees shall file the NDAs with the FDA and will use its reasonable efforts in prosecuting said NDA to approval. IOMED shall thereafter maintain at its own cost the NDAs with the FDA for the term-of this Agreement. Subject to IOMED'S reasonable discretion IOMED hereby agrees to provide to DDS at DDS's own cost access to such NDAs as DDS reasonably requests. **** For the avoidance of doubt, the Parties agree that all information furnished to DDS pursuant to this Paragraph shall constitute CONFIDENTIAL INFORMATION for the purposes of this Agreement.
Sample 1Sample 2Sample 3See All (4)
REGISTRATION OF THE PRODUCTS. 3.1 BEL shall be responsible to promptly inform WELL TALENT of those PRODUCTS which for the lawful marketing and sale requires REGISTRATION in the TERRITORY. BEL shall advise WELL TALENT in writing of the regulatory requirements which must be met to obtain the REGISTRATION and of the requisite information and documentation therefore as well as of such information and documentation which would be helpful to obtain the said REGISTRATION as soon as possible.
Sample 1Sample 2
REGISTRATION OF THE PRODUCTS. 5.1 The Contractor is responsible for submitting the required dossier to obtain the CE xxxx and FDA approval for the Product within 9 months following the date of duly receipt from the Customer of the full and relevant documentation needed at the submitting period, in order to validly submit such applications, and Customer shall bear any pre-approved costs and expenses associated with obtaining the above. Any other requirement needed to access a market for the Products shall also be assumed by the Customer.
Sample 1Sample 2
REGISTRATION OF THE PRODUCTS. 1. During the TERM, JV SUB shall be responsible for filing and prosecuting all PMAs and other applications for regulatory approvals. JV SUB or its sublicensees shall file the PMAs with the FDA and will use its reasonable efforts in prosecuting said PMA to approval. JV SUB shall maintain at its own cost the PMAs with the FDA for the term of this AGREEMENT. JV SUB hereby agrees to provide to ELAN at ELAN's own cost access to such PMAs as ELAN reasonably requests. It is not the intention of the Parties that JV SUB shall furnish to ELAN a copy of each PMA. [CONFIDENTIAL PORTION OMITTED]. During the PMA registration procedure, JV SUB shall keep ELAN promptly and fully advised of JV SUB's registration activities, progress and procedures. For the avoidance of doubt, the Parties agree that all information furnished to ELAN pursuant to this Paragraph shall constitute CONFIDENTIAL INFORMATION for the purposes of this AGREEMENT.
Sample 1
REGISTRATION OF THE PRODUCTS. The Licensee shall file in its own name and/or in the name of its sub-licensee(s), at its own cost or at said sub-licensee(s)’ cost, and in accordance with the regulation in force, country by country, the files for AMM or NDA or Homologation of the Product. The Licensee and/or its sub-licensee(s) shall be the owners of said AMMs or NDA or Homologation of the Product. dépôt d’une telle demande de brevet en son propre nom et à ses frais. Les brevets en propriété conjointe résultant des Améliorations cofinancées par les Parties ou auxquelles elles auront participé conjointement entreront automatiquement dans le champ d’application du présent Contrat. Cette contribution xxxxx être formellement constatée par la conclusion d’un avenant au présent Contrat qui xxxxx préciser les modalités et conditions de la licence et de l’exploitation du nouveau brevet. 5.4 Toute Amélioration de la Technologie Licenciée ou du Produit exclusivement réalisée par le Licencié ou pour son compte, ainsi que l’ensemble des Résultats y afférents, appartiendront au Licencié. 5.5 Chacune des Parties xxxxx obtenir la signature de ses inventeurs sur chacun des documents nécessaires auxdits dépôts de demandes de brevet. ARTICLE 6 –
Sample 1
REGISTRATION OF THE PRODUCTS. 3.1 It is an essential condition of this Agreement that the Products registrations are filed and registered in the name of the Supplier as owner and manufacturer thereof if so required by the laws of the Territories in which the Products are to be sold.
Sample 1
AutoNDA by SimpleDocs

Related to REGISTRATION OF THE PRODUCTS

  • Registration of the Shares Compliance with the Securities Act. --------------------------------------------------------------

  • Registration of the Company’s Securities Subject to the terms of this Agreement, if the Company proposes to Register for its own account any of its Equity Securities, or for the account of any holder (other than a Holder) of Equity Securities any of such holder’s Equity Securities, in connection with the public offering of such securities (except for Exempt Registrations), the Company shall promptly give each Holder written notice of such Registration and, upon the written request of any Holder given within fifteen (15) days after delivery of such notice, the Company shall use its reasonable best efforts to include in such Registration any Registrable Securities thereby requested to be Registered by such Holder. If a Holder decides not to include all or any of its Registrable Securities in such Registration by the Company, such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent Registration Statement or Registration Statements as may be filed by the Company, all upon the terms and conditions set forth herein.

  • Registration of the Common Stock The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing of its initial Business Combination, it shall use its best efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value” (as defined below) by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor statute)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

  • Registration and Listing 15 Section 3.3

  • Registration on Form S-3 Subject to Section 13(f) of this Agreement, if at any time (i) a holder or holders of Restricted Stock then outstanding request that the Company file a registration statement on Form S-3 or any successor thereto for a public offering of all or any portion of the shares of Restricted Stock held by such requesting holder or holders, and (ii) the Company is a registrant entitled to use Form S-3 or any successor thereto to register such shares, then the Company shall use its best efforts to register under the Securities Act on Form S-3 or any successor thereto for public sale in accordance with the method of disposition specified in such notice, the number of shares of Restricted Stock specified in such notice. Whenever the Company is required by this Section 6 to use its best efforts to effect the registration of Restricted Stock, each of the procedures and requirements of Section 4 (including but not limited to the requirement that the Company notify all holders of Restricted Stock from whom notice has not been received and provide them with the opportunity to participate in the offering) shall apply to such registration; provided, however, that there shall be no limitation on the number of registrations on Form S-3 which may be requested and obtained under this Section 6 and registrations effected pursuant to this Section 6 shall not be counted as demands for registration or registrations effected pursuant to Sections 4 or 5, respectively.

  • Registration of Units The Employee’s right to receive the RSU Shares shall be evidenced by book entry (or by such other manner as the Committee may determine).

  • Registration of the Ordinary Shares The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following the closing of its initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the sixty-first (61st) Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the issuance of the Ordinary Shares issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act or another exemption) for that number of Ordinary Shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) less the Warrant Price by (y) the Fair Market Value and (B) 0.361. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume-weighted average price of the Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a “cashless basis” in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the Ordinary Shares issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

Time is Money Join Law Insider Premium to draft better contracts faster.